Extended Clomiphene Citrate Regimen in Women With Polycystic Ovary Syndrome
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
One hundred and thirty six anovulatory women with CC-resistant PCOS were scheduled randomly
into two equal groups. Group A (n=68); received CC (100 mg/day from cycle day 3 for 10 days)
for up to six cycles. Group B (n=68) underwent LOD and followed up for 6 months. The primary
outcome was the ovulation rate in each group; secondary outcomes were midcycle endometrial
thickness and serum estradiol, midluteal serum progesterone, and the rates of clinical
pregnancy and abortion.